I would just like to point out.
The limit of "evidence" based medicine is that it is based around what works best for the most number of patients in a select group.
It is also based on very strict parameters of diagnosis and enrollment.
In medicine, but especially in field medicine, it is often difficult if not impossible to reach definitive conclusions on diagnosis. (Not that we shouldn't try.)
We must be very careful on absolute statements like "always" or "never."
Studies that establish practice guidelines in medicine are invaluable, however, it is also important to recongnize and understand the limitations of them.
One of the things I have noticed, as medicine becomes more fragmented in the effort of hyperspecialization, is that various specialties have stopped communicating or seeking the others advice.
Despite the "decreased complications" and "better outcomes", for various disease states, patients often have more than one disease and the treatments of these noncommunicating specialists often interfere with each other and cause undue patient confusion. Which I strongly suspect increases complications and creates worse outcome. (polypharm is a very good example.)
The limit of "evidence" based medicine is that it is based around what works best for the most number of patients in a select group.
It is also based on very strict parameters of diagnosis and enrollment.
In medicine, but especially in field medicine, it is often difficult if not impossible to reach definitive conclusions on diagnosis. (Not that we shouldn't try.)
We must be very careful on absolute statements like "always" or "never."
Studies that establish practice guidelines in medicine are invaluable, however, it is also important to recongnize and understand the limitations of them.
One of the things I have noticed, as medicine becomes more fragmented in the effort of hyperspecialization, is that various specialties have stopped communicating or seeking the others advice.
Despite the "decreased complications" and "better outcomes", for various disease states, patients often have more than one disease and the treatments of these noncommunicating specialists often interfere with each other and cause undue patient confusion. Which I strongly suspect increases complications and creates worse outcome. (polypharm is a very good example.)